Novartis, UPenn & Tumors: Fishman Explains
09:09 EDT 7 Aug 2012 | Pharmalot
Earlier this week, Novartis and the University of Pennsylvania announced a research and licensing agreement to develop treatments that can activate a patient’s own immune system to fight cancerous tumors. The collaboration is based around targe..
Original Article: Novartis, UPenn & Tumors: Fishman Explains
More From BioPortfolio on "Novartis, UPenn & Tumors: Fishman Explains"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
